CD79A and colorectal carcinoma: Analysis of eight single-cell RNA sequencing (scRNA-seq) datasets and three spatial transcript sequencing (ST-seq) datasets from CRC, along with validation by quantitative reverse transcription-polymerase chain reaction and immunohistochemical staining, demonstrated that IgA inhibits colorectal cancer progression.